Location: Boston, MA
CIK: 0001040508 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $4.482B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | CEREVEL THERAPEUTICS HLDNG I | 65,679,781 | $2.776B | 61.9% | $42.27 | — | — | COM | 15678U128 |
| SGRY | SURGERY PARTNERS INC | 49,946,972 | $1.49B | 33.2% | $29.83 | — | — | COM | 86881A100 |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | 81,600,880 | $203M | 4.5% | $2.49 | — | — | COM | 05356F105 |
| ADV | ADVANTAGE SOLUTIONS INC | 2,890,000 | $12.51M | 0.3% | $4.33 | — | — | COM CL A | 00791N102 |